Advertisement
Screener

Savara Inc (SVRA) Fair Value, Option, Changes in Fair Value, Gain (Loss)

2.8 / 5 stars · 68/120 Roast Me

Savara Inc Fair Value, Option, Changes in Fair Value, Gain (Loss)

Savara Inc (SVRA) reported Fair Value, Option, Changes in Fair Value, Gain (Loss) of -$12.24 million for the 205-month period ending 2013-06-30, per its 10-Q filed 2013-08-05.

Discontinued › Income Statement › Other Income

us-gaap:FairValueOptionChangesInFairValueGainLoss1 · last filed 2013-08-05

  • 2013-06-30: .
  • 2013-03-31: Fair Value, Option, Changes in Fair Value, Gain (Loss) 202 month -$12.24M.
  • 2012-12-31: Fair Value, Option, Changes in Fair Value, Gain (Loss) 199 month -$12.24M.
  • 2012-09-30: Fair Value, Option, Changes in Fair Value, Gain (Loss) 196 month -$12.24M.
Period endFair Value, Option, Changes in Fair Value, Gain (Loss) 193 monthFair Value, Option, Changes in Fair Value, Gain (Loss) 196 monthFair Value, Option, Changes in Fair Value, Gain (Loss) 199 monthFair Value, Option, Changes in Fair Value, Gain (Loss) 202 monthFair Value, Option, Changes in Fair Value, Gain (Loss) 205 month
2013-06-30-$12.24M
10-Q · filed 2013-08-05
2013-03-31-$12.24M
10-Q · filed 2013-05-15
2012-12-31-$12.24M
10-K · filed 2013-03-19
2012-09-30-$12.24M
10-Q · filed 2012-11-05
2012-06-30-$12.24M
10-Q · filed 2012-08-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Seaport Therapeutics, Inc. (SPTX)United States$1.131B